ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 278

$969K Total Retail Price of All Prescriptions

Rank: 33 out of 278

643 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 14,492 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 610 503 1 3
LEVOTHYROXINE SODIUM 583 556 2 2
LISINOPRIL 544 499 3 5
SIMVASTATIN 539 511 4 4
AMLODIPINE BESYLATE 422 380 5 7
FUROSEMIDE 390 377 6 6
HYDROCODONE-ACETAMINOPHEN 368 333 S3 7 1
METOPROLOL TARTRATE 331 306 8 9
ATENOLOL 273 267 9 18
METOPROLOL SUCCINATE 272 258 10 10
LOSARTAN POTASSIUM 251 230 11 24
HYDROCHLOROTHIAZIDE 251 233 11 15
CRESTOR 234 223 13 19
PRAVASTATIN SODIUM 217 191 14 16
METFORMIN HCL 212 178 15 8
ATORVASTATIN CALCIUM 208 205 16 13
CLOPIDOGREL 205 196 17 20
GLYBURIDE 189 155 R 18 88
TRIAMTERENE-HCTZ 176 145 19 58
WARFARIN SODIUM 176 162 19 11
DIOVAN 175 175 21 43
PLAVIX 153 148 22 30
SERTRALINE HCL 148 134 23 25
NEXIUM 141 132 24 14
TAMSULOSIN HCL 135 135 25 32
PREDNISONE 126 118 26 35
ROPINIROLE HCL 126 126 26 69
FLUTICASONE PROPIONATE 126 101 26 44
DOXAZOSIN MESYLATE 126 104 26 131
ALENDRONATE SODIUM 120 108 30 51
POTASSIUM CHLORIDE 117 99 31 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 109 32 31
GABAPENTIN 111 107 33 12
ZOLPIDEM TARTRATE 106 94 34 26
TRAZODONE HCL 106 98 34 47
LOVASTATIN 106 91 34 52
AZITHROMYCIN 103 89 37 39
ALLOPURINOL 102 94 38 38
ADVAIR DISKUS 97 86 39 45
DIGOXIN 95 95 40 40
CARVEDILOL 92 83 41 23
INDAPAMIDE 88 77 42 177
SPIRONOLACTONE 87 86 43 62
LANSOPRAZOLE 86 71 44 93
RANITIDINE HCL 86 79 44 27
ENALAPRIL MALEATE 85 57 46 70
ISOSORBIDE MONONITRATE ER 84 73 47 33
JANUVIA 82 75 48 53
TRAMADOL HCL 76 76 49 22
QUINAPRIL HCL 74 74 50 94
FLUOXETINE HCL 74 58 50 68
GLIPIZIDE ER 73 72 52 136
NIFEDIPINE ER 72 72 53 139
PAROXETINE HCL 70 64 54 57
OXYCODONE-ACETAMINOPHEN 70 53 S2 54 71
PROAIR HFA 70 61 54 34
GLIMEPIRIDE 70 64 54 28
VYTORIN 70 68 54 148
SPIRIVA 70 58 54 49
TRICOR 69 58 60 87
TERAZOSIN HCL 69 61 60 151
CITALOPRAM HBR 68 43 62 21
ONGLYZA 68 48 62 161
CIPROFLOXACIN HCL 68 62 62 65
KLOR-CON M20 66 60 65 42
DIOVAN HCT 63 63 66 110
VERAPAMIL ER 63 53 66 120
DONEPEZIL HCL 62 62 68 29
AMITRIPTYLINE HCL 61 60 R 69 73
SYNTHROID 61 61 69 46
PROPRANOLOL HCL 60 60 71 132
AMLODIPINE BESYLATE-BENAZEPRIL 59 56 72 77
IRBESARTAN 59 59 72 326
LEVEMIR FLEXPEN 58 56 74 162
SINGULAIR 58 50 74 60
METFORMIN HCL ER 58 48 74 76
GEMFIBROZIL 57 45 77 118
LOSARTAN-HYDROCHLOROTHIAZIDE 57 52 77 54
BUPROPION HCL SR 57 55 77 171
FENOFIBRATE 56 51 80 64
EVISTA 55 55 81 166
LORAZEPAM 54 54 82 204
NABUMETONE 53 48 83 164
TRIAMTERENE-HYDROCHLOROTHIAZID 52 52 84 188
DILTIAZEM 24HR CD 51 47 85 95
NAMENDA 50 50 86 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.